Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

38.50
+0.35000.92%
Post-market: 38.500.00000.00%19:30 EDT
Volume:486.07K
Turnover:18.71M
Market Cap:2.24B
PE:12.46
High:38.93
Open:38.13
Low:37.48
Close:38.15
52wk High:40.87
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:0.80
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.24
PE(LYR):14.21

Loading ...

Harmony Biosciences to Report Q2 Results Before US Market Open, Host Conference Call and Webcast

Reuters
·
Jul 21

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)

TIPRANKS
·
Jul 20

Harmony Biosciences Posts Record Q2 WAKIX Revenue

TIPRANKS
·
Jul 17

Harmony Biosciences Price Target Maintained with a $55.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 17

Harmony Biosciences: Strong WAKIX Outperformance and Pipeline Catalysts Support Buy Rating and Unchanged $55 Price Target

TIPRANKS
·
Jul 17

Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down

MT Newswires Live
·
Jul 16

Harmony Biosciences Reaffirms 2026 Net Revenue Outlook of $1 Billion-$1.04 Billion

Reuters
·
Jul 16

GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 Net Revenue Range $1.0B - $1.04B, vs. FactSet Est of $1.01B

MT Newswires Live
·
Jul 16

Harmony Biosciences CFO Reicin Steps Down, Names Mollichella Interim Finance Chief

Reuters
·
Jul 16

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-year 2026 Revenue Guidance, and Announces CFO Transition

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - Reiterates Fy2026 Net Product Revenue Guidance of $1 Bln to $1.04 Bln

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - Announces Preliminary Q2 2026 Wakix Revenue of Approx $261 Mln, up 30% Year over Year

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - Appoints Stephen Mollichella as Interim Principal Financial Officer

THOMSON REUTERS
·
Jul 16

Harmony Biosciences - CFO Glenn Reicin Steps Down Effective July 16, 2026

THOMSON REUTERS
·
Jul 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 08

Harmony Biosciences is Maintained at Hold by Deutsche Bank

Dow Jones
·
Jul 01

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Jun 24

Harmony Biosciences spotlights Phase 3 HBS-301 narcolepsy, idiopathic hypersomnia studies at SLEEP 2026

Reuters
·
Jun 11

Harmony Biosciences to present six narcolepsy, idiopathic hypersomnia posters at SLEEP 2026 meeting

Reuters
·
Jun 11